Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
(Midi does not prescribe this or other unapproved peptides.) What the science says: Theres promising preclinical (aka animal or lab) data on MOTS-c, and early research suggests that MOTS-c may improve metabolism by activating the AMPK pathway and help reverse age-related insulin resistance
BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety
Indianas Board of Pharmacy declined to renew a pharmacy license for CRE8 Pharmacy Group, which had acknowledged compounding retatrutide
Other organizations including MLB and NCAA do not name BPC-157 specifically but include it under peptide hormone bans
That means the registered study cannot currently be used as public evidence for oral BPC bioavailability
Patel estimates that hundreds of thousands of people are using BPC-157 bought on the gray market today
US$ 20.80
US$ 23.22
US$ 23.79
US$ 27.77